| Bioactivity | Cap-dependent endonuclease-IN-19 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-19 is a spirocyclic pyridone derivative. Cap-dependent endonuclease-IN-19 has strong inhibitory effect on RNA polymerase activity of A virus (extracted from patent CN111410661A, compound 1)[1]. |
| Name | Cap-dependent endonuclease-IN-19 |
| CAS | 2567929-06-8 |
| Formula | C28H31N3O4 |
| Molar Mass | 473.56 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wenteng Chen, et al. Spiropyridone derivatives and their applications. Patent CN112047945B. |
Cap-dependent endonuclease-IN-19
CAS: 2567929-06-8 F: C28H31N3O4 W: 473.56
Cap-dependent endonuclease-IN-19 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-I
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.